Large-scale testing (Phase 3)Study completedNCT02296138
What this trial is testing
Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.
Who this might be right for
Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim 7,903